Sr. Scientist, Translational Research
Triveni BioWatertown, Massachusetts, United StatesFull-time2 days ago
Our lead antibody program (TRIV-509) targets kallikreins 5 and 7 (KLK5/7) to directly impact skin barrier function, inflammation, and itch β providing a meaningful and much needed potential treatment option for patients with atopic derma SUMMARY Triveni Bio is seeking anβ¦